It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2012.
2012 | Mumbai, Maharashtra, India | ActiveCoin Pharmaceuticals Private Limited, a active private limited company, was established on 12 June 2012 in Mumbai, Maharashtra, India. Engaging in medicinal chemical & botanical products within the chemicals sector, it holds CIN: U24232MH2012PTC232068. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Hrangdanglien (Director), Jacob Sporon Fiedler (Director). Past directors included Hrangdanglien, Jagruti Samir Upadhyaya, Sherly Justine. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6/A/18, Sonawala Bldg, Tardeo, Mumbai, Maharashtra, 400007.
U24232MH2012PTC232068
232068
12 June 2012
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Coin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hrangdanglien | Director | 22 May 2019 | Current |
| Jacob Sporon Fiedler | Director | 19 Aug 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 20 Aug 2013 | Past |
| Pramod Abcsdd | Director | 01 Oct 2022 | Past |
| Pramod Abcsdd | Director | 15 Jan 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Coin Pharmaceuticals Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2016, Coin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Coin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Coin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Coin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Coin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Hrangdanglien was appointed as a Director was appointed as a Director on 22 May 2019 & has been associated with this company since 6 years 6 months . was documented.
The activity Jacob Sporon Fiedler was appointed as a Director was appointed as a Director on 19 Aug 2013 & has been associated with this company since 12 years 3 months . was completed.
Progress on Coin Pharmaceuticals Private Limited was registered on 12 Jun 2012 with Roc Mumbai & aged 13 years 5 months as per MCA records. was documented.
The CIN of Coin Pharmaceuticals Private Limited is U24232MH2012PTC232068.
Coin Pharmaceuticals Private Limited is headquartered at 6/A/18, Sonawala Bldg, Tardeo, Mumbai, Maharashtra, 400007.
Coin Pharmaceuticals Private Limited was incorporated on 12 June 2012.
The current directors of Coin Pharmaceuticals Private Limited are
The primary industry of Coin Pharmaceuticals Private Limited is Chemicals.
Coin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Coin Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Coin Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX